Hanna Kortejärvi

589 total citations
15 papers, 465 citations indexed

About

Hanna Kortejärvi is a scholar working on Pharmaceutical Science, Materials Chemistry and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Hanna Kortejärvi has authored 15 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmaceutical Science, 5 papers in Materials Chemistry and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Hanna Kortejärvi's work include Drug Solubulity and Delivery Systems (6 papers), Crystallization and Solubility Studies (5 papers) and Drug Transport and Resistance Mechanisms (3 papers). Hanna Kortejärvi is often cited by papers focused on Drug Solubulity and Delivery Systems (6 papers), Crystallization and Solubility Studies (5 papers) and Drug Transport and Resistance Mechanisms (3 papers). Hanna Kortejärvi collaborates with scholars based in Finland, Pakistan and France. Hanna Kortejärvi's co-authors include Marjo Yliperttula, Arto Urtti, Jouni Hirvonen, Leena Peltonen, D.M. Barends, K.K. Midha, Vinod P. Shah, Raisa Laaksonen, Hans E. Junginger and Jennifer Dressman and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Pharmaceutics and Pharmaceutical Research.

In The Last Decade

Hanna Kortejärvi

14 papers receiving 443 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hanna Kortejärvi Finland 12 259 114 102 80 76 15 465
Mario Maio Germany 8 468 1.8× 142 1.2× 76 0.7× 109 1.4× 101 1.3× 10 686
Kerstin J. Frank Germany 7 502 1.9× 203 1.8× 90 0.9× 87 1.1× 97 1.3× 7 582
Jens Van Den Αbeele Belgium 10 233 0.9× 52 0.5× 42 0.4× 45 0.6× 53 0.7× 10 422
Christopher D. Ellison United States 15 154 0.6× 98 0.9× 161 1.6× 50 0.6× 106 1.4× 16 664
Sunanda A. Ranadive United States 6 143 0.6× 73 0.6× 83 0.8× 59 0.7× 41 0.5× 7 460
Cordula Stillhart Switzerland 17 522 2.0× 160 1.4× 95 0.9× 123 1.5× 167 2.2× 32 883
Vilayat A. Sayeed United States 16 297 1.1× 141 1.2× 182 1.8× 123 1.5× 14 0.2× 35 799
Anthony B. Ciavarella United States 10 117 0.5× 23 0.2× 96 0.9× 50 0.6× 49 0.6× 13 348
Matthew Crum Australia 5 309 1.2× 81 0.7× 29 0.3× 81 1.0× 86 1.1× 5 432
Kevin C. Johnson United States 6 438 1.7× 251 2.2× 89 0.9× 119 1.5× 71 0.9× 7 620

Countries citing papers authored by Hanna Kortejärvi

Since Specialization
Citations

This map shows the geographic impact of Hanna Kortejärvi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanna Kortejärvi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanna Kortejärvi more than expected).

Fields of papers citing papers by Hanna Kortejärvi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hanna Kortejärvi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanna Kortejärvi. The network helps show where Hanna Kortejärvi may publish in the future.

Co-authorship network of co-authors of Hanna Kortejärvi

This figure shows the co-authorship network connecting the top 25 collaborators of Hanna Kortejärvi. A scholar is included among the top collaborators of Hanna Kortejärvi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hanna Kortejärvi. Hanna Kortejärvi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Kortejärvi, Hanna, et al.. (2022). Developing an interprofessional people-centred care model for home-living older people with multimorbidities in a primary care health centre: A community-based study. SHILAP Revista de lepidopterología. 5. 100114–100114. 4 indexed citations
2.
Kortejärvi, Hanna, et al.. (2021). Effectiveness and cost-effectiveness of a people-centred care model for community-living older people versus usual care ─ A randomised controlled trial. Research in Social and Administrative Pharmacy. 18(6). 3004–3012. 14 indexed citations
3.
Ojala, K., et al.. (2020). Prediction of drug dissolution from Toremifene 80 mg tablets by NIR spectroscopy. International Journal of Pharmaceutics. 577. 119028–119028. 17 indexed citations
4.
Kortejärvi, Hanna, et al.. (2018). Patient involvement is essential in identifying drug‐related problems. British Journal of Clinical Pharmacology. 84(9). 2048–2058. 29 indexed citations
5.
Kortejärvi, Hanna, et al.. (2014). Pharmacokinetic simulations to explore dissolution criteria of BCS I and III biowaivers with and without MDR-1 efflux transporter. European Journal of Pharmaceutical Sciences. 61. 18–26. 11 indexed citations
6.
Sjöstedt, Noora, Hanna Kortejärvi, Heidi Kidron, et al.. (2013). Challenges of Using In Vitro Data for Modeling P-Glycoprotein Efflux in the Blood-Brain Barrier. Pharmaceutical Research. 31(1). 1–19. 22 indexed citations
7.
Kortejärvi, Hanna, et al.. (2011). Use of conventional surfactant media as surrogates for FaSSIF in simulating in vivo dissolution of BCS class II drugs. European Journal of Pharmaceutics and Biopharmaceutics. 78(3). 531–538. 35 indexed citations
8.
Kortejärvi, Hanna, et al.. (2009). Very rapid dissolution is not needed to guarantee bioequivalence for biopharmaceutics classification system (BCS) I drugs. Journal of Pharmaceutical Sciences. 99(2). 621–625. 16 indexed citations
9.
Kortejärvi, Hanna. (2008). Modelling and simulation approaches for waiving in vivo pharmacokinetic formulation studies. Työväentutkimus Vuosikirja. 1 indexed citations
10.
Laitinen, Leena, Kati‐Sisko Vellonen, Hanna Kortejärvi, et al.. (2007). Effect of cell differentiation and passage number on the expression of efflux proteins in wild type and vinblastine-induced Caco-2 cell lines. European Journal of Pharmaceutics and Biopharmaceutics. 67(2). 548–554. 39 indexed citations
11.
Kortejärvi, Hanna, et al.. (2006). Level A in vitro-in vivo Correlation (IVIVC) Model with Bayesian Approach to Formulation Series. Journal of Pharmaceutical Sciences. 95(7). 1595–1605. 15 indexed citations
12.
Aaltonen, Jaakko, Leena Peltonen, Hanna Kortejärvi, et al.. (2006). In Situ Measurement of Solvent-Mediated Phase Transformations During Dissolution Testing. Journal of Pharmaceutical Sciences. 95(12). 2730–2737. 90 indexed citations
13.
Kortejärvi, Hanna, Arto Urtti, & Marjo Yliperttula. (2006). Pharmacokinetic simulation of biowaiver criteria: The effects of gastric emptying, dissolution, absorption and elimination rates. European Journal of Pharmaceutical Sciences. 30(2). 155–166. 70 indexed citations
14.
Kortejärvi, Hanna, Marjo Yliperttula, Jennifer Dressman, et al.. (2005). Biowaiver monographs for immediate release solid oral dosage forms: Ranitidine hydrochloride. Journal of Pharmaceutical Sciences. 94(8). 1617–1625. 77 indexed citations
15.
Kortejärvi, Hanna, et al.. (2002). Development of level A, B and C in vitro–in vivo correlations for modified-release levosimendan capsules. International Journal of Pharmaceutics. 241(1). 87–95. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026